C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/21/2002	WO2002092805A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
11/21/2002	WO2002092803A1 Phosphotriesterase from agrobacterium radiobacter p230
11/21/2002	WO2002092801A2 Methods and compositions for making emamectin
11/21/2002	WO2002092799A2 Regulation of human steroid 5-alpha reductase-like protein
11/21/2002	WO2002092798A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002	WO2002092786A2 A helper dependent adenoviral vector system and methods for using the same
11/21/2002	WO2002092785A2 Composition and methods relating to ovarian specific genes and proteins
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092780A2 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
11/21/2002	WO2002092777A2 Dwf12 and mutants thereof
11/21/2002	WO2002092775A2 Tumor antigen homologous to poly(a) polymerase
11/21/2002	WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	WO2002092772A2 Antisense modulation of ptp1b expression
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092768A2 Novel alanine transaminase enzyme and methods of use
11/21/2002	WO2002092766A2 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092763A2 Intron associated with myotonic dystrophy type 2 and methods of use
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092757A2 Enzyme over-producing transgenic microorganisms
11/21/2002	WO2002092756A2 Insulin producing cells derived from human embryonic stem cells
11/21/2002	WO2002092741A2 0etergent compositions comprising bacillus subtilis pectate lyases
11/21/2002	WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002	WO2002092635A2 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
11/21/2002	WO2002092628A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
11/21/2002	WO2002092626A2 Cleavage and polyadenylation complex of precursor mrna
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092624A2 G-protein coupled receptor
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092616A1 Antisense permeation enhancers
11/21/2002	WO2002092615A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	WO2002092613A2 Nucleic acid, which binds to gnrh
11/21/2002	WO2002092612A2 Nucleic acids that bind to enterotoxin b
11/21/2002	WO2002092558A1 Polythiourea lipid derivatives
11/21/2002	WO2002092134A1 Lentiviral vectors encoding clotting factors for gene therapy
11/21/2002	WO2002092132A2 Microparticles and methods for delivery of recombinant viral vaccines
11/21/2002	WO2002092128A1 Compositions and methods to regulate serum phosphate
11/21/2002	WO2002092123A2 Method for induction of genome instability
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092069A1 Permeation enhancers
11/21/2002	WO2002092024A2 Compounds and methods for inhibiting axillary malodour
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092012A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092002A2 Screening, diagnostic and therapeutic methods relating to riz
11/21/2002	WO2002092001A2 Compositions and methods for the therapy and diagnosis of lung cancer
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091996A2 Methods for treating cancer
11/21/2002	WO2002091995A2 Method to induce neovascular formation and tissue regeneration
11/21/2002	WO2002091926A2 Inhibitors of dna methyltransferase isoforms
11/21/2002	WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002	WO2002081981A3 Thermoelectric device for dna genomic and proteonic chips and thermo-optical seitching circuits
11/21/2002	WO2002079756A9 Novel molecules of the multi-drug and toxin efflux (mate) protein family and uses thereof
11/21/2002	WO2002079447A9 Avian lysozyme promoter
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002074949A9 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest
11/21/2002	WO2002072845A3 Salmonella promoter for heterologous gene expression
11/21/2002	WO2002064750A3 Expression system for seed proteins
11/21/2002	WO2002064624A3 Improved method for production of secreted proteins in fungi
11/21/2002	WO2002062987A3 Method for producing homogeneous nucleic acid multimers for use in pharmaceutical compositions
11/21/2002	WO2002060340A9 Method for identifying maxi-k channel blockers
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
11/21/2002	WO2002057463A3 Swap/counter selection; a rapid cloning method
11/21/2002	WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002	WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease
11/21/2002	WO2002055712A3 Regulation of human alanine aminotransferase
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002052014A3 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
11/21/2002	WO2002046402A3 Regulation of human patched-like protein
11/21/2002	WO2002046381A3 Method for the prevention or reduction of haze in beverages
11/21/2002	WO2002046359A3 Inducible highly productive raav packaging cell-lines
11/21/2002	WO2002042418A9 3-hydroxypropionic acid and other organic compounds
11/21/2002	WO2002036076A3 Cell lines expressing a mch receptor
11/21/2002	WO2002031201A3 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2002008392A3 Regulation of human matriptase-like serine protease
11/21/2002	WO2002000926A3 Diagnosis of diseases associated with signal transduction
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002	WO2001025462A9 Production of recombinant aav using adenovirus comprising aav rep/cap genes
11/21/2002	WO2001019844A9 Altered nucleotide sequence in cd40 ligand promotor
11/21/2002	US20020174455 Sustained totipotent culture of selected monocot genera
11/21/2002	US20020174454 Overexpression of ABI5 in plants to prevent precocious seed germination and to confer resistance to drought and high salt
11/21/2002	US20020174453 Production of antibodies in transgenic plastids

1 ... 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 ... 4023